Dermapharm Holding SE (CHIX:DMPD) Other Current Liabilities: €244 Mil (As of Mar. 2026)


CHIX:DMPD Dermapharm Holding SE CHIX:DMPD
80 GF Score
Price €46.18
GF Value €38.59
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE Other Current Liabilities?

Dermapharm Holding SE CHIX:DMPD 80 Other Current Liabilities is €244 Mil as of Mar. 2026. GuruFocus rates CHIX:DMPD with a GF Score™ of 80/100 and a GF Value™ of €38.59. The stock has 9 warning signs investors should review.

Dermapharm Holding SE's other current liabilities for the quarter that ended in Mar. 2026 was €244 Mil.

Dermapharm Holding SE's quarterly other current liabilities declined from Sep. 2025 (€172 Mil) to Dec. 2025 (€80 Mil) but then increased from Dec. 2025 (€80 Mil) to Mar. 2026 (€244 Mil).

Dermapharm Holding SE's annual other current liabilities declined from Dec. 2023 (€79 Mil) to Dec. 2024 (€75 Mil) but then increased from Dec. 2024 (€75 Mil) to Dec. 2025 (€80 Mil).

Dermapharm Holding SE Other Current Liabilities Related Terms

Dermapharm Holding SE Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Dermapharm Holding SE's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE Other Current Liabilities Chart

Dermapharm Holding SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.73 45.04 78.64 74.52 80.34

Dermapharm Holding SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.39 91.68 172.41 80.34 243.66
CHIX:DMPD
80GF Score
Dermapharm Holding SE CHIX:DMPD
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dermapharm Holding SE Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €244 Mil mean?
Dermapharm Holding SE (CHIX:DMPD) has a Other Current Liabilities of €244 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dermapharm Holding SE.
Is Dermapharm Holding SE's Other Current Liabilities too high?
Dermapharm Holding SE's current Other Current Liabilities is €244 Mil. Overall, Dermapharm Holding SE has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Other Current Liabilities compare to ZTS and UTHR?
Dermapharm Holding SE's Other Current Liabilities of €244 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dermapharm Holding SE. Dermapharm Holding SE's current Other Current Liabilities is €244 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Dermapharm Holding SE (CHIX:DMPD) has a current Other Current Liabilities of €244 Mil. The stock's GF Value™ is €38.59, compared to a current price of €46.18 — trading 19.7% above its estimated fair value. The current Other Current Liabilities is €244 Mil. Dermapharm Holding SE's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Dermapharm Holding SE (CHIX:DMPD), the current Other Current Liabilities is €244 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dermapharm Holding SE (CHIX:DMPD) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.18 is trading 19.7% above its estimated GF Value™ of €38.59.

Key valuation signals for CHIX:DMPD:

  • Other Current Liabilities: €244 Mil
  • GF Value™: €38.59 vs. price of €46.18 (19.7% above fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the CHIX:DMPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Other Exchanges DMPHF:USA0A5J:UKDMP:Germany
Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
80GF Score

Get the complete analysis for CHIX:DMPD

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.18
Price
€38.59
GF Value